T26	dis 59 84	myelodysplastic syndromes
T1	Token 0 16	Immunomodulatory
T2	Token 17 22	drugs
T3	Token 23 24	(
T4	Token 24 29	IMiDs
T5	Token 29 30	)
T6	Token 30 31	:
T7	Token 32 33	a
T8	Token 34 37	new
T9	Token 38 47	treatment
T10	Token 48 54	option
T11	Token 55 58	for
T12	Token 59 74	myelodysplastic
T13	Token 75 84	syndromes
T14	Token 84 85	.
R1	amod Arg1:T2 Arg2:T1
R2	punct Arg1:T4 Arg2:T3
R3	appos Arg1:T2 Arg2:T4
R4	punct Arg1:T4 Arg2:T5
R5	punct Arg1:T2 Arg2:T6
R6	det Arg1:T10 Arg2:T7
R7	amod Arg1:T10 Arg2:T8
R8	nn Arg1:T10 Arg2:T9
R9	dep Arg1:T2 Arg2:T10
R10	amod Arg1:T13 Arg2:T12
R11	prep_for Arg1:T10 Arg2:T13
R12	punct Arg1:T2 Arg2:T14
T69	che 133 144	thalidomide
T27	Token 86 89	The
T28	Token 90 95	IMiDs
T29	Token 96 105	represent
T30	Token 106 107	a
T31	Token 108 111	new
T32	Token 112 123	proprietary
T33	Token 124 129	class
T34	Token 130 132	of
T35	Token 133 144	thalidomide
T36	Token 145 154	analogues
T37	Token 155 159	that
T38	Token 160 167	possess
T39	Token 168 175	greater
T40	Token 176 183	potency
T41	Token 184 187	and
T42	Token 188 192	less
T43	Token 193 201	toxicity
T44	Token 202 206	than
T45	Token 207 210	the
T46	Token 211 217	parent
T47	Token 218 226	compound
T48	Token 226 227	.
R13	det Arg1:T28 Arg2:T27
R14	nsubj Arg1:T29 Arg2:T28
R15	det Arg1:T33 Arg2:T30
R16	amod Arg1:T33 Arg2:T31
R17	amod Arg1:T33 Arg2:T32
R18	dobj Arg1:T29 Arg2:T33
R19	nsubj Arg1:T38 Arg2:T33
R20	nn Arg1:T36 Arg2:T35
R21	prep_of Arg1:T33 Arg2:T36
R22	rcmod Arg1:T33 Arg2:T38
R23	amod Arg1:T40 Arg2:T39
R24	dobj Arg1:T38 Arg2:T40
R25	advmod Arg1:T43 Arg2:T42
R26	dobj Arg1:T38 Arg2:T43
R27	conj_and Arg1:T40 Arg2:T43
R28	det Arg1:T47 Arg2:T45
R29	amod Arg1:T47 Arg2:T46
R30	prep_than Arg1:T40 Arg2:T47
R31	punct Arg1:T29 Arg2:T48
T70	Token 228 230	As
T71	Token 231 232	a
T72	Token 233 238	group
T73	Token 238 239	,
T74	Token 240 245	these
T75	Token 246 252	agents
T76	Token 253 258	share
T77	Token 259 262	the
T78	Token 263 276	pharmacologic
T79	Token 277 285	property
T80	Token 286 288	of
T81	Token 289 299	modulating
T82	Token 300 308	cellular
T83	Token 309 317	response
T84	Token 318 320	to
T85	Token 321 327	ligand
T86	Token 328 338	activation
T87	Token 338 339	,
T88	Token 340 343	the
T89	Token 344 351	precise
T90	Token 352 360	biologic
T91	Token 361 367	effect
T92	Token 368 370	of
T93	Token 371 376	which
T94	Token 377 379	is
T95	Token 380 384	cell
T96	Token 385 392	lineage
T97	Token 393 396	and
T98	Token 397 416	stimulant-dependent
T99	Token 416 417	.
R32	det Arg1:T72 Arg2:T71
R33	prep_as Arg1:T76 Arg2:T72
R34	punct Arg1:T76 Arg2:T73
R35	det Arg1:T75 Arg2:T74
R36	nsubj Arg1:T76 Arg2:T75
R37	det Arg1:T79 Arg2:T77
R38	amod Arg1:T79 Arg2:T78
R39	dobj Arg1:T76 Arg2:T79
R40	prepc_of Arg1:T79 Arg2:T81
R41	amod Arg1:T83 Arg2:T82
R42	dobj Arg1:T81 Arg2:T83
R43	nn Arg1:T86 Arg2:T85
R44	prep_to Arg1:T83 Arg2:T86
R45	punct Arg1:T83 Arg2:T87
R46	det Arg1:T91 Arg2:T88
R47	amod Arg1:T91 Arg2:T89
R48	amod Arg1:T91 Arg2:T90
R49	dobj Arg1:T81 Arg2:T91
R50	conj_and Arg1:T83 Arg2:T91
R51	dep Arg1:T96 Arg2:T93
R52	dep Arg1:T96 Arg2:T94
R53	nn Arg1:T96 Arg2:T95
R54	prep_of Arg1:T91 Arg2:T96
R55	dobj Arg1:T81 Arg2:T98
R56	conj_and Arg1:T83 Arg2:T98
R57	punct Arg1:T76 Arg2:T99
T188	che 418 430	Lenalidomide
T189	che 432 439	CC-5013
T190	che 441 449	Revlimid
T191	ggp 472 476	IMiD
T192	ggp 611 625	erythropoietin
T122	Token 418 430	Lenalidomide
T123	Token 431 432	(
T124	Token 432 439	CC-5013
T125	Token 439 440	;
T126	Token 441 449	Revlimid
T127	Token 449 450	)
T128	Token 450 451	,
T129	Token 452 453	a
T130	Token 454 460	second
T131	Token 461 471	generation
T132	Token 472 476	IMiD
T133	Token 476 477	,
T134	Token 478 481	has
T135	Token 482 487	shown
T136	Token 488 499	significant
T137	Token 500 514	erythropoietic
T138	Token 515 523	activity
T139	Token 524 526	in
T140	Token 527 535	patients
T141	Token 536 540	with
T142	Token 541 546	lower
T143	Token 547 551	risk
T144	Token 552 555	MDS
T145	Token 556 560	that
T146	Token 561 565	have
T147	Token 566 572	failed
T148	Token 573 575	or
T149	Token 576 579	are
T150	Token 580 583	not
T151	Token 584 594	candidates
T152	Token 595 598	for
T153	Token 599 610	recombinant
T154	Token 611 625	erythropoietin
T155	Token 626 635	treatment
T156	Token 635 636	.
R58	nsubj Arg1:T135 Arg2:T122
R59	punct Arg1:T124 Arg2:T123
R60	abbrev Arg1:T122 Arg2:T124
R61	punct Arg1:T124 Arg2:T125
R62	dep Arg1:T124 Arg2:T126
R63	punct Arg1:T124 Arg2:T127
R64	punct Arg1:T122 Arg2:T128
R65	det Arg1:T132 Arg2:T129
R66	amod Arg1:T132 Arg2:T130
R67	nn Arg1:T132 Arg2:T131
R68	appos Arg1:T122 Arg2:T132
R69	punct Arg1:T122 Arg2:T133
R70	aux Arg1:T135 Arg2:T134
R71	amod Arg1:T138 Arg2:T136
R72	amod Arg1:T138 Arg2:T137
R73	dobj Arg1:T135 Arg2:T138
R74	prep_in Arg1:T135 Arg2:T140
R75	amod Arg1:T144 Arg2:T142
R76	nn Arg1:T144 Arg2:T143
R77	prep_with Arg1:T140 Arg2:T144
R78	nsubj Arg1:T147 Arg2:T144
R79	aux Arg1:T147 Arg2:T146
R80	rcmod Arg1:T144 Arg2:T147
R81	cop Arg1:T151 Arg2:T149
R82	neg Arg1:T151 Arg2:T150
R83	rcmod Arg1:T144 Arg2:T151
R84	conj_or Arg1:T147 Arg2:T151
R85	amod Arg1:T154 Arg2:T153
R86	nn Arg1:T155 Arg2:T154
R87	prep_for Arg1:T151 Arg2:T155
R88	punct Arg1:T135 Arg2:T156
T227	che 662 674	lenalidomide
T228	dis 693 696	MDS
T229	ggp 717 740	erythropoietin receptor
T193	Token 637 643	Unlike
T194	Token 644 652	cytokine
T195	Token 653 660	therapy
T196	Token 660 661	,
T197	Token 662 674	lenalidomide
T198	Token 675 685	suppresses
T199	Token 686 692	select
T200	Token 693 696	MDS
T201	Token 697 703	clones
T202	Token 704 707	and
T203	Token 708 716	enhances
T204	Token 717 731	erythropoietin
T205	Token 732 740	receptor
T206	Token 741 750	signaling
T207	Token 751 753	to
T208	Token 754 761	restore
T209	Token 762 776	erythropoiesis
T210	Token 776 777	.
R89	nn Arg1:T195 Arg2:T194
R90	prep_unlike Arg1:T198 Arg2:T195
R91	punct Arg1:T198 Arg2:T196
R92	nsubj Arg1:T198 Arg2:T197
R93	nsubj Arg1:T203 Arg2:T197
R94	amod Arg1:T201 Arg2:T199
R95	nn Arg1:T201 Arg2:T200
R96	dobj Arg1:T198 Arg2:T201
R97	conj_and Arg1:T198 Arg2:T203
R98	nn Arg1:T206 Arg2:T204
R99	nn Arg1:T206 Arg2:T205
R100	dobj Arg1:T203 Arg2:T206
R101	aux Arg1:T208 Arg2:T207
R102	infmod Arg1:T206 Arg2:T208
R103	dobj Arg1:T208 Arg2:T209
R104	punct Arg1:T198 Arg2:T210
T230	Token 778 786	Activity
T231	Token 787 789	is
T232	Token 790 798	greatest
T233	Token 799 801	in
T234	Token 802 810	patients
T235	Token 811 815	with
T236	Token 816 828	interstitial
T237	Token 829 838	deletions
T238	Token 839 848	involving
T239	Token 849 859	chromosome
T240	Token 860 866	5q31.1
T241	Token 866 867	.
R105	nsubj Arg1:T232 Arg2:T230
R106	cop Arg1:T232 Arg2:T231
R107	prep_in Arg1:T232 Arg2:T234
R108	amod Arg1:T237 Arg2:T236
R109	prep_with Arg1:T234 Arg2:T237
R110	partmod Arg1:T237 Arg2:T238
R111	nn Arg1:T240 Arg2:T239
R112	dobj Arg1:T238 Arg2:T240
R113	punct Arg1:T232 Arg2:T241
T256	Token 868 869	A
T257	Token 870 881	multicenter
T258	Token 882 887	phase
T259	Token 888 890	II
T260	Token 891 896	study
T261	Token 897 905	reported
T262	Token 906 907	a
T263	Token 908 910	76
T264	Token 911 912	%
T265	Token 913 920	overall
T266	Token 921 932	transfusion
T267	Token 933 941	response
T268	Token 942 946	rate
T269	Token 947 949	in
T270	Token 950 971	transfusion-dependent
T271	Token 972 980	patients
T272	Token 981 985	with
T273	Token 986 994	deletion
T274	Token 995 997	5q
T275	Token 997 998	,
T276	Token 999 1003	with
T277	Token 1004 1006	67
T278	Token 1007 1008	%
T279	Token 1009 1018	achieving
T280	Token 1019 1030	transfusion
T281	Token 1031 1043	independence
T282	Token 1044 1049	after
T283	Token 1050 1051	a
T284	Token 1052 1058	median
T285	Token 1059 1067	interval
T286	Token 1068 1070	of
T287	Token 1071 1074	4.6
T288	Token 1075 1080	weeks
T289	Token 1081 1083	of
T290	Token 1084 1093	treatment
T291	Token 1093 1094	.
R114	det Arg1:T260 Arg2:T256
R115	nn Arg1:T260 Arg2:T257
R116	nn Arg1:T260 Arg2:T258
R117	num Arg1:T260 Arg2:T259
R118	nsubj Arg1:T261 Arg2:T260
R119	det Arg1:T268 Arg2:T262
R120	number Arg1:T264 Arg2:T263
R121	amod Arg1:T268 Arg2:T264
R122	amod Arg1:T268 Arg2:T265
R123	nn Arg1:T268 Arg2:T266
R124	nn Arg1:T268 Arg2:T267
R125	dobj Arg1:T261 Arg2:T268
R126	amod Arg1:T271 Arg2:T270
R127	prep_in Arg1:T261 Arg2:T271
R128	prep_with Arg1:T271 Arg2:T273
R129	num Arg1:T273 Arg2:T274
R130	punct Arg1:T261 Arg2:T275
R131	num Arg1:T278 Arg2:T277
R132	prep_with Arg1:T261 Arg2:T278
R133	partmod Arg1:T278 Arg2:T279
R134	nn Arg1:T281 Arg2:T280
R135	dobj Arg1:T279 Arg2:T281
R136	det Arg1:T285 Arg2:T283
R137	amod Arg1:T285 Arg2:T284
R138	prep_after Arg1:T279 Arg2:T285
R139	num Arg1:T288 Arg2:T287
R140	prep_of Arg1:T285 Arg2:T288
R141	prep_of Arg1:T288 Arg2:T290
R142	punct Arg1:T261 Arg2:T291
T316	Token 1095 1106	Cytogenetic
T317	Token 1107 1116	responses
T318	Token 1117 1121	were
T319	Token 1122 1130	observed
T320	Token 1131 1133	in
T321	Token 1134 1136	73
T322	Token 1136 1137	%
T323	Token 1138 1140	of
T324	Token 1141 1149	patients
T325	Token 1150 1154	with
T326	Token 1155 1163	complete
T327	Token 1164 1175	cytogenetic
T328	Token 1176 1185	remission
T329	Token 1186 1188	in
T330	Token 1189 1191	45
T331	Token 1191 1192	%
T332	Token 1193 1201	patients
T333	Token 1201 1202	.
R143	amod Arg1:T317 Arg2:T316
R144	nsubjpass Arg1:T319 Arg2:T317
R145	auxpass Arg1:T319 Arg2:T318
R146	num Arg1:T322 Arg2:T321
R147	prep_in Arg1:T319 Arg2:T322
R148	prep_of Arg1:T322 Arg2:T324
R149	amod Arg1:T328 Arg2:T326
R150	amod Arg1:T328 Arg2:T327
R151	prep_with Arg1:T324 Arg2:T328
R152	num Arg1:T332 Arg2:T330
R153	nn Arg1:T332 Arg2:T331
R154	prep_in Arg1:T328 Arg2:T332
R155	punct Arg1:T319 Arg2:T333
T351	Token 1203 1207	Both
T352	Token 1208 1219	transfusion
T353	Token 1220 1228	response
T354	Token 1229 1232	and
T355	Token 1233 1244	cytogenetic
T356	Token 1245 1253	response
T357	Token 1254 1263	frequency
T358	Token 1264 1268	were
T359	Token 1269 1280	independent
T360	Token 1281 1283	of
T361	Token 1284 1293	karyotype
T362	Token 1294 1304	complexity
T363	Token 1304 1305	,
T364	Token 1306 1313	raising
T365	Token 1314 1324	excitement
T366	Token 1325 1329	that
T367	Token 1330 1334	this
T368	Token 1335 1338	new
T369	Token 1339 1348	treatment
T370	Token 1349 1357	strategy
T371	Token 1358 1363	might
T372	Token 1364 1373	favorably
T373	Token 1374 1379	alter
T374	Token 1380 1383	the
T375	Token 1384 1391	natural
T376	Token 1392 1399	history
T377	Token 1400 1402	of
T378	Token 1403 1410	disease
T379	Token 1411 1413	in
T380	Token 1414 1420	higher
T381	Token 1421 1425	risk
T382	Token 1426 1434	patients
T383	Token 1435 1439	with
T384	Token 1440 1448	deletion
T385	Token 1449 1451	5q
T386	Token 1451 1452	.
R156	preconj Arg1:T353 Arg2:T351
R157	nn Arg1:T353 Arg2:T352
R158	nsubj Arg1:T359 Arg2:T353
R159	amod Arg1:T356 Arg2:T355
R160	conj_and Arg1:T353 Arg2:T356
R161	nsubj Arg1:T359 Arg2:T356
R162	dep Arg1:T353 Arg2:T357
R163	cop Arg1:T359 Arg2:T358
R164	nn Arg1:T362 Arg2:T361
R165	prep_of Arg1:T359 Arg2:T362
R166	punct Arg1:T359 Arg2:T363
R167	xcomp Arg1:T359 Arg2:T364
R168	dobj Arg1:T364 Arg2:T365
R169	complm Arg1:T373 Arg2:T366
R170	det Arg1:T370 Arg2:T367
R171	amod Arg1:T370 Arg2:T368
R172	nn Arg1:T370 Arg2:T369
R173	nsubj Arg1:T373 Arg2:T370
R174	aux Arg1:T373 Arg2:T371
R175	advmod Arg1:T373 Arg2:T372
R176	ccomp Arg1:T365 Arg2:T373
R177	det Arg1:T376 Arg2:T374
R178	amod Arg1:T376 Arg2:T375
R179	dobj Arg1:T373 Arg2:T376
R180	prep_of Arg1:T376 Arg2:T378
R181	amod Arg1:T382 Arg2:T380
R182	nn Arg1:T382 Arg2:T381
R183	prep_in Arg1:T376 Arg2:T382
R184	prep_with Arg1:T382 Arg2:T384
R185	num Arg1:T384 Arg2:T385
R186	punct Arg1:T359 Arg2:T386
T429	che 1453 1465	Lenalidomide
T416	Token 1453 1465	Lenalidomide
T417	Token 1466 1469	was
T418	Token 1470 1478	approved
T419	Token 1479 1481	by
T420	Token 1482 1485	the
T421	Token 1486 1490	U.S.
R187	nsubj Arg1:T418 Arg2:T416
R188	cop Arg1:T418 Arg2:T417
R189	det Arg1:T421 Arg2:T420
R190	prep_by Arg1:T418 Arg2:T421
T483	dis 1596 1599	MDS
T430	Token 1491 1495	Food
T431	Token 1496 1499	and
T432	Token 1500 1504	Drug
T433	Token 1505 1519	Administration
T434	Token 1520 1522	on
T435	Token 1523 1531	December
T436	Token 1532 1534	27
T437	Token 1534 1535	,
T438	Token 1536 1540	2005
T439	Token 1540 1541	,
T440	Token 1542 1545	for
T441	Token 1546 1549	the
T442	Token 1550 1559	treatment
T443	Token 1560 1562	of
T444	Token 1563 1567	IPSS
T445	Token 1568 1571	Low
T446	Token 1572 1575	and
T447	Token 1576 1590	intermediate-1
T448	Token 1591 1595	risk
T449	Token 1596 1599	MDS
T450	Token 1600 1608	patients
T451	Token 1609 1613	with
T452	Token 1614 1617	del
T453	Token 1617 1618	(
T454	Token 1618 1620	5q
T455	Token 1620 1621	)
T456	Token 1622 1633	abnormality
T457	Token 1633 1634	.
R191	nn Arg1:T433 Arg2:T432
R192	conj_and Arg1:T430 Arg2:T433
R193	prep_on Arg1:T430 Arg2:T435
R194	num Arg1:T435 Arg2:T436
R195	punct Arg1:T435 Arg2:T437
R196	appos Arg1:T435 Arg2:T438
R197	punct Arg1:T435 Arg2:T439
R198	det Arg1:T442 Arg2:T441
R199	prep_for Arg1:T430 Arg2:T442
R200	amod Arg1:T450 Arg2:T444
R201	amod Arg1:T450 Arg2:T445
R202	conj_and Arg1:T445 Arg2:T447
R203	amod Arg1:T450 Arg2:T447
R204	nn Arg1:T450 Arg2:T448
R205	nn Arg1:T450 Arg2:T449
R206	prep_of Arg1:T442 Arg2:T450
R207	nn Arg1:T456 Arg2:T452
R208	punct Arg1:T454 Arg2:T453
R209	appos Arg1:T452 Arg2:T454
R210	punct Arg1:T454 Arg2:T455
R211	prep_with Arg1:T450 Arg2:T456
R212	punct Arg1:T430 Arg2:T457
T549	che 1762 1774	lenalidomide
T550	che 1809 1820	darbepoetin
T551	che 1825 1837	lenalidomide
T552	dis 1857 1860	MDS
T553	ggp 1713 1727	erythropoietin
T484	Token 1635 1636	A
T485	Token 1637 1642	phase
T486	Token 1643 1646	III
T487	Token 1647 1657	Intergroup
T488	Token 1658 1663	trial
T489	Token 1664 1665	(
T490	Token 1665 1669	ECOG
T491	Token 1670 1674	2905
T492	Token 1674 1675	)
T493	Token 1676 1680	will
T494	Token 1681 1685	test
T495	Token 1686 1689	the
T496	Token 1690 1698	capacity
T497	Token 1699 1701	to
T498	Token 1702 1712	potentiate
T499	Token 1713 1727	erythropoietin
T500	Token 1728 1736	response
T501	Token 1737 1739	by
T502	Token 1740 1749	comparing
T503	Token 1750 1758	response
T504	Token 1759 1761	to
T505	Token 1762 1774	lenalidomide
T506	Token 1775 1786	monotherapy
T507	Token 1787 1789	to
T508	Token 1790 1793	the
T509	Token 1794 1805	combination
T510	Token 1806 1808	of
T511	Token 1809 1820	darbepoetin
T512	Token 1821 1824	and
T513	Token 1825 1837	lenalidomide
T514	Token 1838 1840	in
T515	Token 1841 1853	non-deletion
T516	Token 1854 1856	5q
T517	Token 1857 1860	MDS
T518	Token 1861 1869	patients
T519	Token 1869 1870	.
R213	det Arg1:T488 Arg2:T484
R214	nn Arg1:T488 Arg2:T485
R215	num Arg1:T488 Arg2:T486
R216	nn Arg1:T488 Arg2:T487
R217	nsubj Arg1:T494 Arg2:T488
R218	punct Arg1:T490 Arg2:T489
R219	appos Arg1:T488 Arg2:T490
R220	num Arg1:T490 Arg2:T491
R221	punct Arg1:T490 Arg2:T492
R222	aux Arg1:T494 Arg2:T493
R223	det Arg1:T496 Arg2:T495
R224	dobj Arg1:T494 Arg2:T496
R225	aux Arg1:T498 Arg2:T497
R226	infmod Arg1:T496 Arg2:T498
R227	nn Arg1:T500 Arg2:T499
R228	dobj Arg1:T498 Arg2:T500
R229	prepc_by Arg1:T498 Arg2:T502
R230	dobj Arg1:T502 Arg2:T503
R231	nn Arg1:T506 Arg2:T505
R232	prep_to Arg1:T503 Arg2:T506
R233	det Arg1:T509 Arg2:T508
R234	prep_to Arg1:T503 Arg2:T509
R235	prep_of Arg1:T509 Arg2:T511
R236	prep_of Arg1:T509 Arg2:T513
R237	conj_and Arg1:T511 Arg2:T513
R238	amod Arg1:T518 Arg2:T515
R239	nn Arg1:T518 Arg2:T516
R240	nn Arg1:T518 Arg2:T517
R241	prep_in Arg1:T502 Arg2:T518
R242	punct Arg1:T494 Arg2:T519
